United Therapeutics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Amarin USD 156.94M 58.98M 2024-09
Ardelyx USD 48.65M 8.78M 2024-12
Baxter International USD 1.76B 344M 2024-12
Bayer EUR 4.02B 2.18B 2025-03
Biogen USD 2.6B 223.3M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Halozyme Therapeutics USD 176.33M 60.48M 2025-03
Insmed USD 403.25M 151.78M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
J&J USD 38.47B 32.35B 2025-03
Moderna USD 1.62B 304M 2025-03
Pfizer USD 1.43B 387M 2025-03
PTC Therapeutics USD 2.03B 1.25B 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Teva Pharmaceutical Industries USD 1.7B 1.6B 2025-03
United Therapeutics USD 1.9B 202.7M 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



United Therapeutics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.